Asahi Kasei is moving the global headquarters for its Healthcare Business to the U.S. The Primary Executive Officer for Healthcare and staff will be located in existing Asahi Kasei offices in Chelmsford, MA.
 
Asahi Kasei’s healthcare business has grown with a lineup of diversified products, ranging from specialized therapeutics to solutions for serious cardiopulmonary conditions, and equipment and services for the manufacture of biotherapeutics. Currently, healthcare accounts for 18% of Asahi Kasei’s revenue and 23% of employees. While 78% of Asahi Kasei’s healthcare sales are outside Japan, further global growth is expected, centered on the U.S.
 
Koshiro Kudo, President and CEO of Asahi Kasei said, “By establishing our Healthcare headquarters in the U.S., the largest healthcare market and source of most innovation, Asahi Kasei reiterates its commitment to further accelerate the growth of its healthcare business. Furthermore, we anticipate that a greater presence in the US with the healthcare team will create synergies and provide benefits for our material and homes businesses. This action is evidence that Asahi Kasei is accelerating its globalization of its group businesses and that we are committed to transforming all operations.”
 
“Today’s announcement shows that Asahi Kasei is moving forward in embracing new methods of operation across all of its business segments,” said Richard Packer, the Primary Executive Officer for Healthcare, “By modifying our governance and management processes to allow one of our major business segments to be managed outside of Japan, we will be better able to move quickly, keep ahead of industry trends, and maintain our competitive edge. We look forward to better connecting our people and technologies to the global healthcare market. Similar connections will be made to our material and homes operations in the US.”